BioArctic AB's (publ) partner Eisai announced today that the Biologics License Application (BLA) for the subcutaneous formulation (subcutaneous autoinjector: SC-AI) of Leqembi (lecanemab) for ...
VANCOUVER, BC / ACCESS Newswire / January 6, 2026 / Nevada Lithium Resources Inc. (TSXV:NVLH)(OTCQB:NVLHF)(FSE:87K) ("Nevada Lithium" or the "Company") is pleased to announce the identification of sig ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback